Alpha Cure Therapeutics
- Biotech or pharma, therapeutic R&D
Alpha Cure Therapeutics is developing precision safe (non-radioactive) radioligand therapy via small molecule next-generation BNCT.
We aim to cure Breast Cancer, including Triple Negative Breast Cancer (and other cancers)
Our technology is unique in the precision intracellular targeting of clinically validated mutant cancer proteins. A bimodal approach of BNCT alpha particle therapy and targeted pathway therapy.